The translational immunologist and research professor at Perelman School of Medicine, University of Pennsylvania, discussed persistence of CD4+ CAR T-cells in CLL.
Jan Joseph Melenhorst, PhD
Advertisement
Articles by Jan Joseph Melenhorst, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Autologous Stem Cell Therapy for Alzheimer Disease Advances to Phase 2 After Positive Early Findings
2
FDA Approves BMS’s Liso-Cel for R/R Marginal Zone Lymphoma
3
CGTLive®’s Weekly Rewind – December 5, 2025
4
ImmunoLogic, Episode 7: "Turbocharging CAR T-Cells: The IL-9 Orthogonal Signal" With Anusha Kalbasi, MD
5
